The inhibitor of apoptosis protein (IAP) antagonist Debio 1143 enhances the immune response to anti-PD1/L1 inhibitors in vitro and in vivo

Presented at AACR 2018, Chicago, US

A. Attinger, B. Gavillet, A. Vaslin Chessex, N. Wiedemann, G. Vuagniaux

Debiopharm International SA, Lausanne, Switzerland.